Cargando...
Cerebrospinal fluid neurogranin and YKL‐40 as biomarkers of Alzheimer's disease
OBJECTIVE: Widespread implementation of cerebrospinal fluid (CSF) biomarkers of Alzheimer's disease (AD) in clinical settings requires improved accuracy for diagnosis of prodromal disease and for distinguishing AD from non‐AD dementias. Novel and promising CSF biomarkers include neurogranin, a...
Gardado en:
| Publicado en: | Ann Clin Transl Neurol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4704480/ https://ncbi.nlm.nih.gov/pubmed/26783546 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.266 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|